CALLAN JMB INC.
For the period ended Mar 31, 2025. Filed May 15, 2025.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2025 · Filed May 15, 2025
CJMB$0.30+6.0%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Unaudited Financial Statements Condensed Consolidated Balance Sheets as of March 31, 2025 and December 31, 2024
CONDENSED CONSOLIDATED BALANCE SHEETS as of
March 31, 2025 (Unaudited) AND DECEMBER 31, 2024
| March 31, 2025 | December 31, 2024 | |
|---|---|---|
| Assets | ||
| Current Assets: | ||
| Cash | $5,219,929 | $2,097,945 |
| Accounts receivable, net of allowance for credit losses of $129,606 and $64,000, respectively | 834,956 | 622,914 |
| Inventory | 216,046 | 158,362 |
| Related party loans | - | 18,669 |
| Tax refund receivable | - | 6,377 |
| Prepaid insurance | 350,845 | 151,354 |
| Other current assets | 180,328 | 127,542 |
| Deferred offering costs | - | 136,025 |
| Total current assets | 6,802,104 | 3,319,188 |
| Right of use asset | 799,739 | 883,029 |
| Property and equipment, net | 853,823 | 876,682 |
| Security deposit | - | 3,650 |
| Total assets | $8,455,666 | $5,082,549 |
| Liabilities and Stockholders’ Equity | ||
| Current Liabilities: | ||
| Accounts payable | $389,941 | $371,661 |
| Accrued expenses – Note 5 | 390,461 | 506,381 |
| Corporate taxes payable | 27,106 | 23,000 |
| Deferred revenue | 5,045 | 94,097 |
| Right of use liability – current | 236,343 | 279,176 |
| Total current liabilities | 1,048,896 | 1,274,315 |
| Right of use liability | 592,587 | 628,274 |
| Deferred tax liability | 6,602 | 6,602 |
| Total long-term liabilities | 599,189 | 634,876 |
| Total liabilities | 1,648,085 | 1,909,191 |
| Stockholders’ Equity | ||
| Preferred stock - authorized 10,000,000 shares, $0.001 par value; zero issued and outstanding as of March 31, 2025 and December 31, 2024 | - | - |
| Common stock - authorized 190,000,000 shares, par value $0.001 par value; 4,443,569 issued and outstanding as of March 31, 2025 and 3,000,000 December 31, 2024 | 4,444 | 3,000 |
| Additional Paid in Capital | 10,337,375 | 5,464,006 |
| Accumulated Deficit | (3,534,238) | (2,293,648) |
| Total Stockholders’ Equity | 6,807,581 | 3,173,358 |
| Total Liabilities and Stockholders’ Equity | $8,455,666 | $5,082,549 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.